Blue Rock Advisors’s Boston Scientific BSX Stock Holding History

Blue Rock Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27,154	Closed	-$1.04M	–	40
2020 Q3	$1.04M	Buy	+27,154	New	+$1.05M	0.9%	44

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Blue Rock Advisors's BSX Position: Q4 2020 in Review

Blue Rock Advisors sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 27,154 shares — an estimated $1.04M sold.

Blue Rock Advisors first reported a position in BSX in Q3 2020 and held it in 1 quarter. The position peaked at $1.04M in Q3 2020. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

Blue Rock Advisors reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 27,154 Boston Scientific shares in Q4 2020, an estimated $1.04M.
Blue Rock Advisors first reported a position in Boston Scientific in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's Boston Scientific position peaked at $1.04M in Q3 2020.
863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.